NON-EXCLUSIVE PATENT LICENSE UNDER THE SANDIA RAPID TECHNOLOGY DEPLOYMENT PROGRAM (SHORT FORM)Non-Exclusive Patent License • October 28th, 2020 • Delaware
This License is between National Technology & Engineering Solutions of Sandia, LLC (“NTESS”), manager and operator of Sandia National Laboratories (“SNL”) for the United States Department of Energy (hereinafter “DOE”) under contract DE NA0003525, a Delaware limited liability company whose principal place of business is located in Albuquerque, New Mexico, and
NON-EXCLUSIVE PATENT LICENSENon-Exclusive Patent License • December 31st, 2007 • Alma Lasers Ltd. • Massachusetts
For clarity and without limitation, in addition to using optical radiation to remove hair, an Alma Hair Product may further use optical radiation for treatment of skin (including treatment of vascular and pigmented lesions, acne, wrinkles, scars and tattoos, and for other dermatological applications), and other treatment or cosmetic purpose(s).
ContractNon-Exclusive Patent License • June 5th, 2006 • Palomar Medical Technologies Inc • Electromedical & electrotherapeutic apparatus • Massachusetts
NON-EXCLUSIVE PATENT LICENSE THIS NON-EXCLUSIVE PATENT LICENSE (this “Agreement”) is entered into as of June 2, 2006 (the “Effective Date”), and shall be treated as in full force and effect as of April 1, 2006, by and between Palomar Medical Technologies, Inc., a Delaware corporation, with offices at 82 Cambridge Street, Burlington, MA 01803 (“Palomar”), and Cutera, Inc., a Delaware corporation with offices at 3240 Bayshore Blvd., Brisbane, CA 94005 (“Cutera”) (Palomar on the one hand, and Cutera together with all Cutera Affiliates (as defined below) on the other hand, each a “Party”, and together, the “Parties”). WITNESSETH: WHEREAS, Palomar and Cutera (as successor in interest to the rights and obligations of Altus Medical, Inc.) are parties to certain patent-related Lawsuits (as defined in the Settlement Agreement (as defined below)); WHEREAS, Palomar and MGH (as defined below), on the one hand, and Cutera, on the other hand, have agreed to enter into that certain Settlement Agreeme
NON-EXCLUSIVE PATENT LICENSENon-Exclusive Patent License • March 28th, 2013 • Delaware
This License is between Sandia Corporation (“Sandia”), manager and operator of Sandia National Laboratories for the United States Department of Energy (hereinafter “DOE”) under contract DE-AC04-94AL85000, a Delaware corporation whose principal place of business is located in Albuquerque, New Mexico, and
ContractNon-Exclusive Patent License • October 26th, 2006 • Palomar Medical Technologies Inc • Electromedical & electrotherapeutic apparatus • Massachusetts
NON-EXCLUSIVE PATENT LICENSE THIS NON-EXCLUSIVE PATENT LICENSE (this “Agreement”) is entered into this 18th day of October, 2006 (the “Execution Date”), and shall be treated as in full force and effect as of July 1, 2006 (the “Effective Date”), by and between Palomar Medical Technologies, Inc., a Delaware corporation, with offices at 82 Cambridge Street, Burlington, MA 01803 (“Palomar”), and Laserscope, a California corporation with offices at 3070 Orchard Drive, San Jose, CA 95134-2011 (“Laserscope”) (Palomar on the one hand, and Laserscope together with all Laserscope Affiliates (as defined below) on the other hand, each a “Party”, and together, the “Parties”). WITNESSETH: WHEREAS, Palomar has a license from MGH under the Anderson Patents (both as defined below) relating to the use of light to remove hair; WHEREAS, Palomar and Laserscope are parties to that certain Patent License Agreement, dated October 15, 1999, as amended (the “Original Agreement”); WHEREAS, Palomar and Laserscope
PUBLIC HEALTH SERVICE AMENDMENT L-007-96/1Non-Exclusive Patent License • June 29th, 2004 • Xenova Group PLC • Biological products, (no disgnostic substances)
This Amendment of the Non-Exclusive Patent License, L-007-96/0 (“Agreement”), L-007-96/1 (“Amendment”), is made between the National Institutes of Health (“NIH”), the Centers for Disease Control and Prevention (“CDC”), or the Food and Drug Administration (“FDA”), hereinafter singly or collectively referred to as (“PHS”), agencies of the United States Public Health Service within the Department of Health and Human Services (“DHHS”) through the Office of Technology Transfer, NIH, having an address at 6011 Executive Boulevard, Suite 325, Rockville, Maryland 20852-3804, U.S.A., and Amersham Health Inc. (“Licensee”), having an office at 101 Carnegie Center, Princeton, New Jersey 08540).
NON-EXCLUSIVE PATENT LICENSENon-Exclusive Patent License • November 7th, 2006 • Cynosure Inc • Electromedical & electrotherapeutic apparatus • Massachusetts
** This material has been omitted pursuant to a request for confidential treatment and has been filed separately with the SEC. An aggregate of 17 pages were omitted pursuant to a request for confidential treatment and filed separately with the SEC.
ContractNon-Exclusive Patent License • November 7th, 2006 • Palomar Medical Technologies Inc • Electromedical & electrotherapeutic apparatus • Massachusetts
NON-EXCLUSIVE PATENT LICENSE THIS NON-EXCLUSIVE PATENT LICENSE (this “Agreement”) is entered into this 6th day of November, 2006 (the “Effective Date”), and shall be treated as in full force and effect as of October 1, 2006, by and between Palomar Medical Technologies, Inc., a Delaware corporation, with offices at 82 Cambridge Street, Burlington, MA 01803 (“Palomar”), and Cynosure, Inc., a Delaware corporation with offices at 5 Carlisle Road, Westford, MA 01886 (“Cynosure”) (Palomar together with all Palomar Affiliates (as defined below) on the one hand, and Cynosure together with all Cynosure Affiliates (as defined below) on the other hand, each a “Party”, and together, the “Parties”). WITNESSETH: WHEREAS, Palomar has a license from MGH under the Anderson Patents (both as defined below) relating to the use of light to remove hair; WHEREAS, Cynosure and Cynosure Affiliates desire to obtain, and Palomar is willing to grant, a non-exclusive, royalty-bearing sublicense under the Anderson
NON-EXCLUSIVE PATENT LICENSENon-Exclusive Patent License • June 6th, 2006 • Cutera Inc • Electromedical & electrotherapeutic apparatus • Massachusetts
** This material has been omitted pursuant to a request for confidential treatment and has been filed separately with the SEC. An aggregate of 17 pages were omitted pursuant to a request for confidential treatment and filed separately with the SEC.
